Hengrui Therapeutics

About:

Hengrui Therapeutics is a oncology drug startup

Website: http://www.hengruitherapeutics.com/

Top Investors: HR Bio Holdings

Description:

HTI is a U.S. biopharmaceutical company dedicated to developing and commercializing innovative drugs to address unmet medical needs. HTI’s current therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss in the pipeline.